Skip to main content
Premium Trial:

Request an Annual Quote

New Products: LifeCodexx's PraenaTest; Almac's Sequencing Services


GATC Biotech subsidiary LifeCodexx has launched PraenaTest, a noninvasive, sequencing-based test to detect fetal trisomy 21. The CE-marked test is available in 70 prenatal clinics and hospitals in Germany, Austria, Liechtenstein, and Switzerland. LifeCodexx licensed the rights to the sequencing-based detection method from Sequenom.

Almac is now offering next-generation sequencing services in its CLIA-certified laboratory. The company said it will initially offer targeted resequencing services on the Illumina MiSeq. The service is particularly geared toward pharmaceutical companies developing molecular diagnostic tests and companion diagnostics.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.